Cargando…

Time‐trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF‐STENT Registry

BACKGROUND: The management of atrial fibrillation and flutter (AF) patients undergoing percutaneous coronary intervention (PCI) has undergone a rapid recent evolution. In 2016, the Canadian Cardiovascular Society (CCS) published expert recommendations to help guide clinicians in balancing bleeding a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boivin‐Proulx, Laurie‐Anne, Deneault‐Marchand, Ariane, Matteau, Alexis, Mansour, Samer, Gobeil, François, Camm, John A., Fox, Keith A. A., Potter, Brian J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2019
Materias:	Quality and Outcomes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068069/ https://www.ncbi.nlm.nih.gov/pubmed/31850592 http://dx.doi.org/10.1002/clc.23316

Ejemplares similares

Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines Uptake
por: Beaulieu, Marie-Claude, et al.
Publicado: (2021)

Anticoagulation in patients with atrial fibrillation and heart failure: Insights from the NCDR PINNACLE‐AF registry
por: Contreras, Johanna P., et al.
Publicado: (2019)

Effect of Real-Time Physician Oversight of Prehospital STEMI Diagnosis on ECG-Inappropriate and False Positive Catheterization Laboratory Activation
por: Boivin-Proulx, Laurie-Anne, et al.
Publicado: (2020)

Prehospital STEMI Referral Systems and Sex-Related Bias in Canada: A National Survey
por: Boivin-Proulx, Laurie-Anne, et al.
Publicado: (2022)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
por: Marquis-Gravel, Guillaume, et al.
Publicado: (2017)

Percutaneous coronary intervention and 30‐day unplanned readmission with chest pain in the United States (Nationwide Readmissions Database)
por: Sykes, RobertA., et al.
Publicado: (2021)

Evolution of and Evidence-Practice Gaps in Antithrombotic Management of Atrial Fibrillation Patients After Percutaneous Coronary Intervention
por: Boivin-Proulx, Laurie-Anne, et al.
Publicado: (2022)

Impact of STEMI Diagnosis and Catheterization Laboratory Activation Systems on Sex- and Age-Based Differences in Treatment Delay
por: Pacheco, Christine, et al.
Publicado: (2021)

Mortality and guideline‐directed medical therapy in real‐world heart failure patients with reduced ejection fraction
por: McCullough, Peter A., et al.
Publicado: (2021)

Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
por: Gandra, Shravanthi R., et al.
Publicado: (2016)

Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban
por: Tamayo, Sally, et al.
Publicado: (2015)

Association between anxiety and clinical outcomes in Chinese patients with myocardial infarction in the absence of obstructive coronary artery disease
por: He, Chao‐Jie, et al.
Publicado: (2020)

Diabetes association with self‐reported health, resource utilization, and prognosis post‐myocardial infarction
por: Nicolau, José C., et al.
Publicado: (2020)

The impact of short hospital stay on prognosis after acute myocardial infarction: An analysis from the ACSIS database
por: Tomer, Orr, et al.
Publicado: (2021)

Device infections related to cardiac resynchronization therapy in clinical practice–An analysis of its prevalence, risk factors and routine surveillance at a single center university hospital
por: Ostrowska, Bozena, et al.
Publicado: (2021)

Gender differences in acute myocardial infarction—A nationwide German real‐life analysis from 2014 to 2017
por: Kuehnemund, Leonie, et al.
Publicado: (2021)

Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter
por: Haddad, Kevin, et al.
Publicado: (2021)

Comparison of Systematic Ticagrelor-Based Dual Antiplatelet Therapy to Selective Triple Antithrombotic Therapy for Left Ventricle Dysfunction Following Anterior STEMI
por: Bastiany, Alexandra, et al.
Publicado: (2018)

Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failure
por: Nath, Mintu, et al.
Publicado: (2022)

My Best Chum
Publicado: (1912)

The economic considerations of patients and caregivers in choice of dialysis modality
por: Walker, Rachael C., et al.
Publicado: (2016)

Working Agenda for Black Mothers: A Position Paper From the Association of Black Cardiologists on Solutions to Improving Black Maternal Health
por: Bond, Rachel M., et al.
Publicado: (2021)

Is triple antithrombotic therapy a safe option in patients with AF who receive drug-eluting stents?: a review article
por: Alshahrani, Ali, et al.
Publicado: (2023)

Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF
por: Kozieł, Monika, et al.
Publicado: (2021)

Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From the CONNECT AF+PCI Study
por: Valle, Felipe H., et al.
Publicado: (2021)

Quality-of-Life Outcomes With Minimally Invasive Transforaminal Lumbar Interbody Fusion Based on Long-Term Analysis of 304 Consecutive Patients
por: Perez-Cruet, Mick J., et al.
Publicado: (2014)

Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry
por: Pope, Marita Knudsen, et al.
Publicado: (2021)

What is the patient experience of surgical care during the coronavirus disease 2019 (COVID-19) pandemic? A mixed-methods study at a single institution
por: Shannon, Adrienne B., et al.
Publicado: (2021)

Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint
por: Curtis, Melissa D., et al.
Publicado: (2018)

Involvement of hormones in olfactory imprinting and homing in chum salmon
por: Ueda, Hiroshi, et al.
Publicado: (2016)

The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program
por: Beier, Lea, et al.
Publicado: (2022)

Longitudinal electrocardiographic assessment in Brugada syndrome
por: Daw, Jonathan M., et al.
Publicado: (2022)

Treatment Outcome of Metastatic Spine Tumor in Lung Cancer Patients: Did the Treatments Improve Their Outcomes?
por: Uei, Hiroshi, et al.
Publicado: (2017)

Prognostic predictors of early mortality from exsanguination in adult trauma: a Malaysian trauma center experience
por: Huei, Tan Jih, et al.
Publicado: (2017)

Reduced duration of stay after elective colorectal surgery during the peak phase of COVID-19 pandemic: A positive effect of infection risk awareness?
por: Spinelli, Antonino, et al.
Publicado: (2021)

Measuring cataract outcomes
por: Buchan, John
Publicado: (2022)

Genetic assessment of a summer chum salmon metapopulation in recovery
por: Small, Maureen P, et al.
Publicado: (2014)

Erratum: Involvement of hormones in olfactory imprinting and homing in chum salmon
por: Ueda, Hiroshi, et al.
Publicado: (2016)

Dataset for characterization of thrombospondin family in chum salmon (Oncorhynchus keta)
por: Lee, Sang Yoon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tndr4g9bgqv7eep9us5rgqh6bv